Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

biote (BTMD) Other Accumulated Expenses: 2021-2025

Historic Other Accumulated Expenses for biote (BTMD) over the last 5 years, with Q3 2025 value amounting to $2.3 million.

  • biote's Other Accumulated Expenses rose 82.86% to $2.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.3 million, marking a year-over-year increase of 82.86%. This contributed to the annual value of $1.5 million for FY2024, which is 1842.25% down from last year.
  • As of Q3 2025, biote's Other Accumulated Expenses stood at $2.3 million, which was up 82.86% from $2.0 million recorded in Q2 2025.
  • biote's 5-year Other Accumulated Expenses high stood at $4.2 million for Q3 2023, and its period low was $424000.0 during Q1 2023.
  • Its 5-year average for Other Accumulated Expenses is $1.7 million, with a median of $1.6 million in 2024.
  • The largest annual percentage gain for biote's Other Accumulated Expenses in the last 5 years was 27334.91% (2024), contrasted with its biggest fall of 4589.43% (2024).
  • Over the past 5 years, biote's Other Accumulated Expenses (Quarter) stood at $1.1 million in 2021, then tumbled by 40.62% to $649000.0 in 2022, then soared by 185.21% to $1.9 million in 2023, then decreased by 18.42% to $1.5 million in 2024, then soared by 53.11% to $2.3 million in 2025.
  • Its Other Accumulated Expenses stands at $2.3 million for Q3 2025, versus $2.0 million for Q2 2025 and $2.3 million for Q1 2025.